MEDIROM Healthcare Technologies
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of MEDIROM Healthcare Technologies generated cash of -$631,737,000, which is more than the previous year. Cash used in financing activities reached the amount of $461,206,000 last year. Net change in cash is therefore -$499,107,000.
Cash Flow
| 2018 | 141.87M | -79.38M | -74.47M |
|---|---|---|---|
| 2019 | 7.87M | -37.93M | 331.99M |
| 2020 | -366.42M | -139.59M | 1.43B |
| 2021 | -557.23M | -83.93M | -427.94M |
| 2022 | -685.69M | 580.43M | 340.09M |
| 2023 | -631.73M | -328.57M | 461.20M |
MRM Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 605.45M | 370.61M | 1.43B | 513.62M | 211.68M | 223.67M |
Operating activities | ||||||
Net income | 115.04M | 148.96M | -990.73M | -539.17M | 17.33M | 66.31M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 252.59M | 184.05M | 126.24M | 62.29M | 46.17M | 44.26M |
Stock-based compensation expense | 0 | 0 | 196.85M | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 196.85M | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 580.68M | -222.38M | -37.02M | 189.14M | -66.87M | 30.17M |
Inventories | -25.87M | -95.40M | -2.44M | -2.44M | 892K | 6.92M |
Accounts payable | -69.88M | 0 | 58.43M | -55.57M | 0 | 88.51M |
Cash generated by operating activities | -631.73M | -685.69M | -557.23M | -366.42M | 7.87M | 141.87M |
Investing activities | ||||||
Purchases Of Investments | -3.09M | 0 | -78.92M | -26.70M | 0 | -40.50M |
Investments In Property Plant And Equipment | -135.84M | -120.74M | -113.77M | -104.12M | -7.40M | -50.11M |
Acquisitions Net | 0 | -148M | 54.24M | -99.19M | -3.20M | -109.51M |
Cash generated by investing activities | -328.57M | 580.43M | -83.93M | -139.59M | -37.93M | -79.38M |
Financing activities | ||||||
Common Stock Issued | 0 | 0 | 0 | 1.16B | 700M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 300.91M | 502.34M | -251.08M | -386.44M | -241.91M | -344.47M |
Cash used in financing activities | 461.20M | 340.09M | -427.94M | 1.43B | 331.99M | -74.47M |
Net Change In Cash | -499.10M | 234.83M | -1.06B | 926.11M | 301.93M | -11.99M |
Cash at end of period | 106.34M | 605.45M | 370.61M | 1.43B | 513.62M | 211.68M |
| Data source | Data source | Data source | Data source |